Rachel M. Bailey

2.4k total citations · 1 hit paper
29 papers, 1.9k citations indexed

About

Rachel M. Bailey is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Rachel M. Bailey has authored 29 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Neurology and 8 papers in Physiology. Recurrent topics in Rachel M. Bailey's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Alzheimer's disease research and treatments (6 papers) and Hereditary Neurological Disorders (6 papers). Rachel M. Bailey is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Alzheimer's disease research and treatments (6 papers) and Hereditary Neurological Disorders (6 papers). Rachel M. Bailey collaborates with scholars based in United States, Australia and Czechia. Rachel M. Bailey's co-authors include Leonard Petrucelli, Dennis W. Dickson, Chad A. Dickey, Yong‐Jie Zhang, Steven J. Gray, Cam Patterson, Ya-Fei Xu, Judith Dunmore, Sahana Nagabhushan Kalburgi and Emanuele Buratti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Rachel M. Bailey

26 papers receiving 1.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins

2007 507 citations Chad A. Dickey, Adeela Kamal et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rachel M. Bailey United States	18	1.0k	663	575	348	333	29	1.9k
Judith Dunmore United States	6	935 0.9×	425 0.6×	570 1.0×	327 0.9×	286 0.9×	8	1.5k
Anand Goswami Germany	22	1.6k 1.5×	510 0.8×	267 0.5×	432 1.2×	648 1.9×	39	2.3k
Maxime W.C. Rousseaux United States	19	913 0.9×	587 0.9×	302 0.5×	169 0.5×	404 1.2×	39	1.7k
Nathalie Brouwers Belgium	26	1.2k 1.1×	668 1.0×	1.6k 2.7×	309 0.9×	263 0.8×	46	2.6k
Monica Castanedes‐Casey United States	21	924 0.9×	1.3k 1.9×	626 1.1×	127 0.4×	327 1.0×	30	2.0k
Robert Spoelgen Germany	16	1.1k 1.0×	476 0.7×	1.1k 1.9×	529 1.5×	579 1.7×	21	2.4k
Bart Dermaut Belgium	31	1.9k 1.8×	872 1.3×	1.3k 2.3×	232 0.7×	540 1.6×	64	3.3k
Sashi Kesavapany United States	29	1.6k 1.5×	996 1.5×	999 1.7×	616 1.8×	803 2.4×	38	3.1k
Wenbo Zhou United States	22	1.2k 1.1×	927 1.4×	479 0.8×	158 0.5×	712 2.1×	45	2.3k
Marie‐Paule Muriel France	22	1.2k 1.1×	841 1.3×	322 0.6×	287 0.8×	1.1k 3.2×	30	2.5k

Countries citing papers authored by Rachel M. Bailey

Since Specialization

Citations

This map shows the geographic impact of Rachel M. Bailey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel M. Bailey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel M. Bailey more than expected).

Fields of papers citing papers by Rachel M. Bailey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel M. Bailey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel M. Bailey. The network helps show where Rachel M. Bailey may publish in the future.

Co-authorship network of co-authors of Rachel M. Bailey

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel M. Bailey. A scholar is included among the top collaborators of Rachel M. Bailey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel M. Bailey. Rachel M. Bailey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kavanaugh, Brian C., Tanya L. Brown, Judy Liu, et al.. (2024). Sleep Abnormalities in SLC13A5 Citrate Transporter Disorder. Genes. 15(10). 1338–1338.

Kavanaugh, Brian C., Tanya L. Brown, Judy Liu, et al.. (2024). Developmental phenotype and quality of life in SLC13A5 citrate transporter disorder. Developmental Medicine & Child Neurology. 67(7). 930–940.

Bailey, Rachel M., et al.. (2024). Expression and distribution of rAAV9 intrathecally administered in juvenile to adolescent mice. Gene Therapy. 32(3). 189–196. 1 indexed citations

Goodspeed, Kimberly, Rachel M. Bailey, Suyash Prasad, et al.. (2022). Gene Therapy: Novel Approaches to Targeting Monogenic Epilepsies. Frontiers in Neurology. 13. 805007–805007. 6 indexed citations

Presa, Maximiliano, Rachel M. Bailey, Crystal Davis, et al.. (2021). AAV9-mediated FIG4 delivery prolongs life span in Charcot-Marie-Tooth disease type 4J mouse model. Journal of Clinical Investigation. 131(11). 24 indexed citations

Bailey, Rachel M., et al.. (2021). Preclinical studies to support the intrathecal delivery of scAAV9/SUMF1 as a gene replacement therapy for multiple sulfatase deficiency. Molecular Genetics and Metabolism. 132(2). S17–S18. 2 indexed citations

Bailey, Rachel M., et al.. (2021). Gene Transfer Therapy for Neurodevelopmental Disorders. Developmental Neuroscience. 43(3-4). 230–240. 22 indexed citations

Bailey, Rachel M., et al.. (2020). Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies. Brain Research. 1739. 146832–146832. 53 indexed citations

Bardai, Farah, et al.. (2018). Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics. PLoS Biology. 16(12). e2006265–e2006265. 43 indexed citations

10.

Bailey, Rachel M., Diane Armao, Sahana Nagabhushan Kalburgi, & Steven J. Gray. (2018). Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy. Molecular Therapy — Methods & Clinical Development. 9. 160–171. 87 indexed citations

11.

Bailey, Rachel M., et al.. (2015). 15. Development of Intrathecal scAAV9 Gene Therapy for Giant Axonal Neuropathy. Molecular Therapy. 23. S6–S7. 1 indexed citations

12.

Kantor, Boris, et al.. (2014). Methods for Gene Transfer to the Central Nervous System. Advances in genetics. 87. 125–197. 81 indexed citations

13.

Bailey, Rachel M., John Howard, Joshua A. Knight, et al.. (2014). Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model. Molecular Neurodegeneration. 9(1). 8–8. 26 indexed citations

14.

Pérez, Pablo D., Gabrielle Hall, Tetsuya Kimura, et al.. (2013). In vivo functional brain mapping in a conditional mouse model of human tauopathy (taup301l) reveals reduced neural activity in memory formation structures. Molecular Neurodegeneration. 8(1). 9–9. 34 indexed citations

15.

Cannon, Ashley, Baoli Yang, Joshua A. Knight, et al.. (2012). Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction. Acta Neuropathologica. 123(6). 807–823. 45 indexed citations

16.

Dickey, Chad A., John Koren, Yong‐Jie Zhang, et al.. (2008). Akt and CHIP coregulate tau degradation through coordinated interactions. Proceedings of the National Academy of Sciences. 105(9). 3622–3627. 174 indexed citations

17.

VanWert, Adam L., Rachel M. Bailey, & Douglas H. Sweet. (2007). Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G. American Journal of Physiology-Renal Physiology. 293(4). F1332–F1341. 67 indexed citations

18.

Dickey, Chad A., Adeela Kamal, Karen Lundgren, et al.. (2007). The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. Journal of Clinical Investigation. 117(3). 648–658. 507 indexed citations breakdown →

19.

Zhang, Yong‐Jie, Ya-Fei Xu, Chad A. Dickey, et al.. (2007). Progranulin Mediates Caspase-Dependent Cleavage of TAR DNA Binding Protein-43. Journal of Neuroscience. 27(39). 10530–10534. 319 indexed citations

20.

Sridharan, Vijayalakshmi, Jason L. Guichard, Rachel M. Bailey, et al.. (2006). The prolyl hydroxylase oxygen-sensing pathway is cytoprotective and allows maintenance of mitochondrial membrane potential during metabolic inhibition. American Journal of Physiology-Cell Physiology. 292(2). C719–C728. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact